Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ABBOTT INDIA ALKEM LABORATORIES/
ABBOTT INDIA
 
P/E (TTM) x 37.5 50.0 75.0% View Chart
P/BV x 6.5 18.2 35.9% View Chart
Dividend Yield % 1.0 1.2 83.9%  

Financials

 ALKEM LABORATORIES   ABBOTT INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
ABBOTT INDIA
Mar-23
ALKEM LABORATORIES/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3,62522,482 16.1%   
Low Rs2,83516,156 17.5%   
Sales per share (Unadj.) Rs970.12,517.0 38.5%  
Earnings per share (Unadj.) Rs84.2446.8 18.8%  
Cash flow per share (Unadj.) Rs110.2479.7 23.0%  
Dividends per share (Unadj.) Rs50.00325.00 15.4%  
Avg Dividend yield %1.51.7 92.0%  
Book value per share (Unadj.) Rs756.41,480.5 51.1%  
Shares outstanding (eoy) m119.5721.25 562.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.37.7 43.4%   
Avg P/E ratio x38.443.2 88.7%  
P/CF ratio (eoy) x29.340.3 72.8%  
Price / Book Value ratio x4.313.0 32.7%  
Dividend payout %59.472.7 81.6%   
Avg Mkt Cap Rs m386,207410,513 94.1%   
No. of employees `000NANA-   
Total wages/salary Rs m21,3145,636 378.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,99353,487 216.9%  
Other income Rs m2,1611,543 140.0%   
Total revenues Rs m118,15355,030 214.7%   
Gross profit Rs m15,06512,055 125.0%  
Depreciation Rs m3,104700 443.6%   
Interest Rs m1,074160 671.4%   
Profit before tax Rs m13,04812,738 102.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9803,244 91.8%   
Profit after tax Rs m10,0689,494 106.0%  
Gross profit margin %13.022.5 57.6%  
Effective tax rate %22.825.5 89.7%   
Net profit margin %8.717.8 48.9%  
BALANCE SHEET DATA
Current assets Rs m86,06430,251 284.5%   
Current liabilities Rs m37,07112,060 307.4%   
Net working cap to sales %42.234.0 124.2%  
Current ratio x2.32.5 92.6%  
Inventory Days Days3387 37.5%  
Debtors Days Days672 3,102.1%  
Net fixed assets Rs m37,24515,135 246.1%   
Share capital Rs m239213 112.5%   
"Free" reserves Rs m90,20831,248 288.7%   
Net worth Rs m90,44731,460 287.5%   
Long term debt Rs m00-   
Total assets Rs m124,54145,386 274.4%  
Interest coverage x13.280.7 16.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.2 79.0%   
Return on assets %8.921.3 42.1%  
Return on equity %11.130.2 36.9%  
Return on capital %15.641.0 38.1%  
Exports to sales %14.60.4 3,526.5%   
Imports to sales %010.8 0.0%   
Exports (fob) Rs m16,916221 7,647.5%   
Imports (cif) Rs mNA5,765 0.0%   
Fx inflow Rs m16,916310 5,460.4%   
Fx outflow Rs m4,1905,818 72.0%   
Net fx Rs m12,727-5,508 -231.1%   
CASH FLOW
From Operations Rs m16,8258,934 188.3%  
From Investments Rs m1,128-1,477 -76.4%  
From Financial Activity Rs m-17,608-6,387 275.7%  
Net Cashflow Rs m4161,070 38.9%  

Share Holding

Indian Promoters % 56.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 24.4 8.9 273.5%  
FIIs % 8.5 0.2 4,716.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 25.0 173.0%  
Shareholders   65,184 72,252 90.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Abbott India Share Price Performance

Period ALKEM LABORATORIES Abbott India S&P BSE HEALTHCARE
1-Day -1.18% 0.74% 1.18%
1-Month -0.99% -5.97% -0.75%
1-Year 52.26% 24.80% 61.82%
3-Year CAGR 21.70% 21.40% 18.16%
5-Year CAGR 22.99% 29.91% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Abbott India paid Rs 325.0, and its dividend payout ratio stood at 72.7%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.